Quality of life in men undergoing active surveillance for localized prostate cancer
- PMID: 23271780
- PMCID: PMC3540887
- DOI: 10.1093/jncimonographs/lgs026
Quality of life in men undergoing active surveillance for localized prostate cancer
Abstract
Active surveillance is an important arrow in the quiver of physicians advising men with prostate cancer. Quality-of-life considerations are paramount for patient-centered decision making. Although the overall deleterious impact on health is less dramatic than for those who pursue curative treatment, men on active surveillance also suffer sexual dysfunction and distress. Five-year outcomes revealed more erectile dysfunction (80% vs 45%) and urinary leakage (49% vs 21%) but less urinary obstruction (28% vs 44%) in men undergoing prostatectomy. Bowel function, anxiety, depression, well-being, and overall health-related quality of life (HRQOL) were similar after 5 years, but at 6-8 years, other domains of HRQOL, such as anxiety and depression, deteriorated significantly for those who chose watchful waiting. Further research is needed to compare prospectively HRQOL outcomes in men choosing active surveillance and those never diagnosed with prostate cancer, in part to help weigh the potential benefits and harms of prostate cancer screening.
Comment in
-
Re: quality of life in men undergoing active surveillance for localized prostate cancer.J Urol. 2013 Aug;190(2):536-7. doi: 10.1016/j.juro.2013.04.118. Epub 2013 May 2. J Urol. 2013. PMID: 23845333 No abstract available.
Similar articles
-
Sexual function with localized prostate cancer: active surveillance vs radical therapy.BJU Int. 2012 Oct;110(7):1032-9. doi: 10.1111/j.1464-410X.2011.10846.x. Epub 2012 Jan 19. BJU Int. 2012. PMID: 22260273
-
Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.Lancet Oncol. 2011 Sep;12(9):891-9. doi: 10.1016/S1470-2045(11)70162-0. Epub 2011 Aug 5. Lancet Oncol. 2011. PMID: 21821474 Clinical Trial.
-
Quality of life after radical prostatectomy or watchful waiting.N Engl J Med. 2002 Sep 12;347(11):790-6. doi: 10.1056/NEJMoa021483. N Engl J Med. 2002. PMID: 12226149 Clinical Trial.
-
Quality of life following radical prostatectomy.Crit Rev Oncol Hematol. 2002 Aug;43(2):141-51. doi: 10.1016/s1040-8428(02)00026-4. Crit Rev Oncol Hematol. 2002. PMID: 12191736 Review.
-
Active surveillance for prostate cancer: past, present and future.Curr Opin Oncol. 2012 May;24(3):243-50. doi: 10.1097/CCO.0b013e3283527f99. Curr Opin Oncol. 2012. PMID: 22450149 Free PMC article. Review.
Cited by
-
Prostate cancer.Nat Rev Dis Primers. 2021 Feb 4;7(1):9. doi: 10.1038/s41572-020-00243-0. Nat Rev Dis Primers. 2021. PMID: 33542230 Review.
-
Dynamic Changes of Generic Quality of Life after Different Treatments for Localized Prostate Cancer.J Clin Med. 2021 Jan 5;10(1):158. doi: 10.3390/jcm10010158. J Clin Med. 2021. PMID: 33466363 Free PMC article.
-
Comparing Perspectives of Canadian Men Diagnosed With Prostate Cancer and Health Care Professionals About Active Surveillance.J Patient Exp. 2020 Dec;7(6):1122-1129. doi: 10.1177/2374373520932735. Epub 2020 Jun 11. J Patient Exp. 2020. PMID: 33457554 Free PMC article.
-
The Quality of Life among Men Receiving Active Surveillance for Prostate Cancer: An Integrative Review.Healthcare (Basel). 2019 Jan 22;7(1):14. doi: 10.3390/healthcare7010014. Healthcare (Basel). 2019. PMID: 30678213 Free PMC article. Review.
-
Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium.Eur Urol. 2019 Mar;75(3):523-531. doi: 10.1016/j.eururo.2018.10.025. Epub 2018 Oct 29. Eur Urol. 2019. PMID: 30385049 Free PMC article.
References
-
- Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011; 61(4):212–236 - PubMed
-
- Revelo MP, Cookson MS, Chang SS, et al. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol. 2004; 171(2, pt 1):646–651 - PubMed
-
- Moutzouris G, Barbatis C, Plastiras D, et al. Incidence and histological findings of unsuspected prostatic adenocarcinoma in radical cystoprostatectomy for transitional cell carcinoma of the bladder. Scand J Urol Nephrol. 1999; 33(1):27–30 - PubMed
-
- Abbas F, Hochberg D, Civantos F, et al. Incidental prostatic adenocarcinoma in patients undergoing radical cystoprostatectomy for bladder cancer. Eur Urol. 1996; 30(3):322–326 - PubMed
-
- Sakr WA, Grignon DJ, Crissman JD, et al. High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20–69: an autopsy study of 249 cases. In Vivo. 1994; 8(3):439–443 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
